Stephanie Ann Snyder, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 215 Thomas More Pkwy Ste A, Crestview Hills, KY 41017 Phone: 859-341-9588 Fax: 859-341-0078 |
William B. Hoppenjans, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2701 Chancellor Dr, Crestview Hills, KY 41017 Phone: 859-341-1878 Fax: 859-341-0560 |
Scott Andrew Neltner, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2701 Chancellor Dr, Crestview Hills, KY 41017 Phone: 859-341-1878 Fax: 859-341-0560 |
Dr. Sarah Eilerman Weinel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 215 Thomas More Pkwy Ste A, Crestview Hills, KY 41017 Phone: 859-341-9588 Fax: 859-341-0078 |
Dr. Jason Robert Martin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 651 Centre View Blvd, Crestview Hills, KY 41017 Phone: 859-371-3376 Fax: 859-331-1053 |
Dr. Nicole Marie Warner, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 651 Centre View Blvd, Crestview Hills, KY 41017 Phone: 859-301-6647 Fax: 859-331-0809 |
News Archive
A study in the American Journal of Critical Care found a remarkably high prevalence of delirium in a small cohort of critically ill patients treated with therapeutic hypothermia after cardiac arrest.
Keryx Biopharmaceuticals, Inc. today announced that Phase 1 data of KRX-0401 (perifosine) in recurrent pediatric solid tumors was presented yesterday in the pediatric solid tumor poster discussion session held at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, IL.
Researchers are now able to study stem cells from the brains of adult mice and their neurogenesis in long-term cell cultures.
Parent Project Muscular Dystrophy, a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) awarded University of Washington a $148,000 grant to continue the functional analysis of spectrin-like repeats in dystrophin.
C-CIT Sensors AG, today announced the release of its new sensor product allowing to monitor glucose and lactate in-situ and over weeks using one single-use sensor. The product will be exhibited at booth 1732 during the BioProcess International Conference & Exhibition in the Hynes Convention Center, from 4-7 September 2018 and is available for beta testing as of 4 September 2018.
› Verified 4 days ago